Encapsulated Glioma — Trials

Encapsulated Glioma — Trials · CancerIndex

Clinical trials

Registered studies

328 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 116
Recruiting: 55
Ph III recruiting: 5
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (51)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05393258	Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas	completed	N/A	13	Washington University School of MedicineOTHER	1	Mar 17, 2026	clinicaltrials
NCT02162732	Molecular-Guided Therapy for Childhood Cancer	completed	N/A	186	Giselle ShollerOTHER	2	Nov 3, 2025	clinicaltrials